Publicacións (22) Publicacións nas que participase algún/ha investigador/a

filter_list Internal Medicine

2022

  1. Development of a mouse model for spontaneous oral squamous cell carcinoma in Fanconi anemia

    Oral Oncology, Vol. 134

2021

  1. LA VACUNACIÓN en cachorros

    Argos: Informativo Veterinario, Núm. 231, pp. 1-20

2020

  1. Serological evaluation of selected vector-borne pathogens in owned dogs from northern Spain based on a multicenter study using a commercial test

    Parasites and Vectors, Vol. 13, Núm. 1

2018

  1. Polymerase chain reaction detection of Bartonella spp. in dogs from Spain with blood culture-negative infectious endocarditis

    Journal of Veterinary Cardiology, Vol. 20, Núm. 4, pp. 267-275

2017

  1. A transposon-based analysis reveals RASA1 is involved in triple-negative breast cancer

    Cancer Research, Vol. 77, Núm. 6, pp. 1357-1368

  2. Caso clínico de medicina interna

    Clínica veterinaria de pequeños animales: revista oficial de AVEPA, Asociación Veterinaria Española de Especialistas en Pequeños Animales, Vol. 37, Núm. 3, pp. 202-208

  3. Context-dependent role of IKKβ in cancer

    Genes, Vol. 8, Núm. 12

  4. IKKβ-mediated resistance to skin cancer development is Ink4a/Arf-dependent

    Molecular Cancer Research, Vol. 15, Núm. 9, pp. 1255-1264

2016

  1. IKKα regulates the stratification and differentiation of the epidermis: Implications for skin cancer development

    Oncotarget, Vol. 7, Núm. 47, pp. 76779-76792

  2. Protective role of p53 in skin cancer: Carcinogenesis studies in mice lacking epidermal p53

    Oncotarget, Vol. 7, Núm. 15, pp. 20902-20918

2011

  1. CYLD regulates keratinocyte differentiation and skin cancer progression in humans

    Cell Death and Disease, Vol. 2, Núm. 9

  2. IKKβ overexpression leads to pathologic lesions in stratified epithelia and exocrine glands and to tumoral transformation of oral epithelia

    Molecular Cancer Research, Vol. 9, Núm. 10, pp. 1329-1338

  3. Increased IKKα expression in the basal layer of the epidermis of transgenic mice enhances the malignant potential of skin tumors

    PLoS ONE, Vol. 6, Núm. 7

2010

  1. An inactivating CYLD mutation promotes skin tumor progression by conferring enhanced proliferative, survival and angiogenic properties to epidermal cancer cells

    Oncogene, Vol. 29, Núm. 50, pp. 6522-6532

2009

  1. Akt activation synergizes with Trp53 loss in oral epithelium to produce a novel mouse model for head and neck squamous cell carcinoma

    Cancer Research, Vol. 69, Núm. 3, pp. 1099-1108

2008

  1. Glucocorticoid receptor is required for skin barrier competence

    Endocrinology, Vol. 149, Núm. 3, pp. 1377-1388

  2. Transrepression function of the glucocorticoid receptor regulates eyelid development and keratinocyte proliferation but is not sufficient to prevent skin chronic inflammation

    Molecular Endocrinology, Vol. 22, Núm. 4, pp. 799-812

2007

  1. Deregulated activity of Akt in epithelial basal cells induces spontaneous tumors and heightened sensitivity to skin carcinogenesis

    Cancer Research, Vol. 67, Núm. 22, pp. 10879-10888

2005

  1. Targeted overexpression of leptin to keratinocytes in transgenic mice results in lack of skin phenotype but induction of early leptin resistance

    Endocrinology, Vol. 146, Núm. 10, pp. 4167-4176

  2. Utilización de las sales aniónicas en la prevención de la paresia puerperal hipocalcémica

    Archivos de Medicina Veterinaria, Vol. 37, Núm. 1, pp. 7-13